{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:37:19Z","timestamp":1778549839309,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1111\/j.1745-7254.2008.00826.x","type":"journal-article","created":{"date-parts":[[2008,8,5]],"date-time":"2008-08-05T02:58:22Z","timestamp":1217905102000},"page":"951-964","source":"Crossref","is-referenced-by-count":12,"title":["Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K\/Akt signaling pathway in a caspase-3-dependent manner<sup>1<\/sup>"],"prefix":"10.1038","volume":"29","author":[{"given":"Jian","family":"HUANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"YANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"LIU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"JIN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1182\/asheducation-2003.1.176","article-title":"Myelodysplastic syndrome","author":"Mufti","year":"2003","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB2","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1182\/asheducation-2005.1.156","article-title":"Molecular pathogenesis of MDS","author":"Look","year":"2005","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB3","volume-title":"Pathology and genetics of tumours of haematopoietic and lymphoid tissues","author":"Jaffe","year":"2001"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1159\/000074488","article-title":"The myelodysplastic syndromes: a matter of life or death","volume":"111","author":"Parker","year":"2004","journal-title":"Acta Haematol"},{"issue":"(suppl1)","key":"10.1111\/j.1745-7254.2008.00826.x-BIB5","first-page":"1","article-title":"Antineoplastons: history of the research (I)","volume":"12","author":"Burzynski","year":"1986","journal-title":"Drugs Exp Clin Res"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB6","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0304-3835(00)00408-0","article-title":"Potential utility of antineoplaston A-10 levels in breast cancer","volume":"155","author":"Badria","year":"2000","journal-title":"Cancer Lett"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1142\/S0192415X01000101","article-title":"Effect of CDA-II, urinary preparation, on lipofuscin, lipid peroxidation and antioxidant systems in young and middle-aged rat brain","volume":"29","author":"Lin","year":"2001","journal-title":"Am J Chin Med"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.fct.2005.08.029","article-title":"Inhibitory effect of CDA-II, a urinary preparation, on aflatoxin B(1)-induced oxidative stress and DNA damage in primary cultured rat hepatocytes","volume":"44","author":"Lin","year":"2006","journal-title":"Food Chem Toxicol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB9","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1089\/acm.2005.11.903","article-title":"Differentiation of pheochromocytoma PC12 cells induced by human urine extract and the involvement of the extracellular signal-regulated kinase signaling pathway","volume":"11","author":"Yao","year":"2005","journal-title":"J Altern Complement Med"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB10","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/10428199709114174","article-title":"In vitro culture studies of childhood myelodysplastic syndrome: establishment of the cell line MUTZ-1","volume":"25","author":"Steube","year":"1997","journal-title":"Leuk Lymphoma"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0145-2126(99)90169-8","article-title":"Malignant hematopoietic cell lines: in vitro models for the study of myelodysplastic syndromes","volume":"24","author":"Drexler","year":"2000","journal-title":"Leuk Res"},{"issue":"(Suppl 1)","key":"10.1111\/j.1745-7254.2008.00826.x-BIB12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/sj.cdd.4401556","article-title":"Apoptosis-based therapies and drug targets","volume":"12","author":"Fischer","year":"2005","journal-title":"Cell Death Differ"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB13","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S0006-2952(01)00916-9","article-title":"Mechanisms of apoptosis by the tyrphostin AG957 in hematopoietic cells","volume":"63","author":"Urbano","year":"2002","journal-title":"Biochem Pharmacol"},{"issue":"20","key":"10.1111\/j.1745-7254.2008.00826.x-BIB14","first-page":"221","article-title":"Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death","volume":"279","author":"Chandrasekar","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB15","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0092-8674(00)00009-X","article-title":"Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins","volume":"102","author":"Verhagen","year":"2000","journal-title":"Cell"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB16","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.exphem.2007.09.007","article-title":"Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome","volume":"35","author":"Kerbauy","year":"2007","journal-title":"Exp Hematol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB17","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1182\/blood-2005-04-1424","article-title":"NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs)","volume":"106","author":"Kerbauy","year":"2005","journal-title":"Blood"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1593\/neo.06376","article-title":"E3 ubiquitin ligases as cancer targets and biomarkers","volume":"8","author":"Sun","year":"2006","journal-title":"Neoplasia"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB19","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1161\/01.RES.88.3.262","article-title":"Nuclear factor-kappaB and cell survival: IAPs call for support","volume":"88","author":"Lee","year":"2001","journal-title":"Circ Res"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.188.1.211","article-title":"Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis","volume":"188","author":"Stehlik","year":"1998","journal-title":"J Exp Med"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB21","doi-asserted-by":"crossref","first-page":"7342","DOI":"10.1038\/sj.onc.1204926","article-title":"Transcriptional regulation of bcl-2 by nuclear factor kappa B and its significance in prostate cancer","volume":"20","author":"Catz","year":"2001","journal-title":"Oncogene"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB22","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1128\/MCB.21.16.5299-5305.2001","article-title":"NF-kappaB signals induce the expression of c-FLIP","volume":"21","author":"Micheau","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB23","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","article-title":"NF-kappaB in development and progression of human cancer","volume":"446","author":"Dolcet","year":"2005","journal-title":"Virchows Arch"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1101\/gad.12.6.806","article-title":"Essential contribution of caspase 3\/CPP32 to apoptosis and its associated nuclear changes","volume":"12","author":"Woo","year":"1998","journal-title":"Genes Dev"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/bies.1115","article-title":"Physiology and pathophysiology of poly(ADP-ribosyl) ation","volume":"23","author":"Burkle","year":"2001","journal-title":"Bioessays"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB26","first-page":"27","article-title":"Poly (ADP-ribose) polymerase: a guardian angel protecting the genome and suppressing tumorigenesis","volume":"1552","author":"Tong","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB27","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR-ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.ceb.2005.02.010","article-title":"Recent advances in the protein kinase B signaling pathway","volume":"17","author":"Woodgett","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/sj.leu.2404057","article-title":"Frequent elevation of Akt kinase phosphorylation in blood marrow and peripheral blood mononuclear cells from high-risk myelodysplastic syndrome patients","volume":"20","author":"Ny\u00e0kern","year":"2006","journal-title":"Leukemia"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2004.11.051","article-title":"Activation of PI3K\/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line","volume":"97","author":"Lee","year":"2005","journal-title":"Gynecol Oncol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB31","first-page":"5988","article-title":"Inhibition of Bad phosphorylation either at serine-112 via extracellular signal-regulated protein kinase cascade or at serine-136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin","volume":"60","author":"Hayakawa","year":"2000","journal-title":"Cancer Res"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB32","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1101\/gad.13.22.2905","article-title":"Cellular survival: a play in three Akts","volume":"13","author":"Datta","year":"1999","journal-title":"Genes Dev"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB33","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1101\/gad.11.6.701","article-title":"The PI3-kinase\/Akt signaling pathway delivers an anti-apoptotic signal","volume":"11","author":"Kennedy","year":"1997","journal-title":"Genes Dev"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/5042","article-title":"PIK3CA is implicated as an oncogene in ovarian cancer","volume":"21","author":"Shayesteh","year":"1999","journal-title":"Nat Genet"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB35","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1073\/pnas.96.2.429","article-title":"Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-kappaB activation","volume":"96","author":"B\u00e9raud","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB36","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2005-05-1989","article-title":"NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome","volume":"107","author":"Braun","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB37","first-page":"1005","article-title":"Nuclear factor kappa B is activated in myelodysplastic bone marrow cells","volume":"87","author":"Sanz","year":"2002","journal-title":"Haematologica"},{"issue":"17","key":"10.1111\/j.1745-7254.2008.00826.x-BIB38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1074\/jbc.M500077200","article-title":"Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion","volume":"280","author":"Takada","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB39","doi-asserted-by":"crossref","first-page":"4943","DOI":"10.1128\/MCB.11.10.4943","article-title":"Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts","volume":"11","author":"Baldwin","year":"1991","journal-title":"Mol Cell Biol"},{"issue":"25","key":"10.1111\/j.1745-7254.2008.00826.x-BIB40","first-page":"245","article-title":"Integration of Rac-dependent regulation of cyclin D1 transcription through a nuclear factor-kappaB-dependent pathway","volume":"274","author":"Joyce","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB41","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB42","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjp.0707288","article-title":"Mitochondrial medicine: pharmacological targeting of mitochondria in disease","volume":"151","author":"Armstrong","year":"2007","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB43","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB44","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1182\/blood-2002-06-1714","article-title":"Amount of spontaneous apoptosis detected by Bax\/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML)","volume":"101","author":"Del Poeta","year":"2003","journal-title":"Blood"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB45","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1038\/sj.emboj.7601126","article-title":"Bcl-2 changes conformation to inhibit Bax oligomerization","volume":"25","author":"Dlugosz","year":"2006","journal-title":"EMBO J"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB46","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/1568011053765967","article-title":"Cisplatin is a DNA-damaging antitumour compound triggering multifactorial biochemical responses in cancer cells: importance of apoptotic pathways","volume":"5","author":"Sedletska","year":"2005","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB47","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.leukres.2006.02.014","article-title":"Stress-induced in vitro apoptosis of native human acute myelogenous leukemia (AML)cells shows a wide variation between patients and is associated with low BCL-2:Bax ratio and low levels of heat shock protein 70 and 90","volume":"30","author":"Ryningen","year":"2006","journal-title":"Leuk Res"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB48","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1182\/blood-2005-09-3898","article-title":"Triptolide induces caspase-dependent cell death mediated via the mitochondrial pathway in leukemic cells","volume":"108","author":"Carter","year":"2006","journal-title":"Blood"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB49","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1074\/jbc.M312044200","article-title":"Akt phosphorylation and stabilization of X-linked inhibitor of apoptosis protein (XIAP)","volume":"279","author":"Dan","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB50","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.leukres.2004.03.020","article-title":"Expression of IAP family proteins in myelodysplastic syndromes transforming to overt leukemia","volume":"28","author":"Yamamoto","year":"2004","journal-title":"Leuk Res"},{"key":"10.1111\/j.1745-7254.2008.00826.x-BIB51","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1038\/sj.leu.2403180","article-title":"Expression of FLIP(Long) and FLIP(Short) in bone marrow mono-nuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis","volume":"17","author":"Benesch","year":"2003","journal-title":"Leukemia"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T03:06:34Z","timestamp":1684811194000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/doifinder\/10.1111\/j.1745-7254.2008.00826.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1745-7254.2008.00826.x","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}